Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-05-10-Speech-2-312"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20050510.26.2-312"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
".
The Commission considers the objective of providing patients with better information on medicinal products a high priority and is, therefore, working in different areas with a view to improving the situation.
First of all, Article 88a of Directive 2001/83 calls upon the Commission to present to Parliament and the Council a report on current practice with regard to information provision – particularly on the Internet – and its risks and benefits for patients. The report will be prepared following consultations with patients' and consumers' organisations, doctors' and pharmacists' organisations, Member States and interested parties. It is due within three years of the entry into force of Regulation (EC) No 2004/726/EC – which means by 2007 – but the Commission will do its best to present this report in advance of that deadline. In accordance with the results of the report, the Commission is to table proposals setting out an information strategy to ensure good-quality, objective, reliable and non-promotional information on medicinal products and other treatments and address the question of the information source's liability.
Secondly, the G10 process: the report will also take into account experience from related activities in this area, such as the work of the European Medicines Agency with patient organisations, the public-private partnership under the G10 initiative and other relevant activities, such as the new European database on medicinal products. The Regulation I already mentioned calls upon the European Medicines Agency to set up a publicly accessible database, which will cover medicines authorised by the Community and by Member States. The database will facilitate the search for information already authorised for package leaflets and will contain a section on paediatric medicines. The final report will then need to address the question of whether, beyond the stocktaking of current practice, with its risks and benefits, an improved information strategy is needed and what elements could be included.
The third matter is the European Union Public Health Programme running from 2003 until 2008, which has as its objective the creation of a comprehensive and reliable information and knowledge system. That is being created on the basis of a shortlist of agreed indicators for which data is collected mainly through Eurostat and ad hoc services and projects. Analysis of data is supported through the programme, leading to regular reporting on public health issues. All project reports are published on the Commission public health website. In addition, in order to improve the presentation and availability of information to the public, to specialised audiences and to patients, the Commission is at an advanced stage of preparing an EU public health portal, drawing together information at EU level, national and regional levels, and with resources from civil society. It is planned to launch this initiative before the end of this year."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples